By mapping genetic predispositions before or early in treatment, PlexusDx helps patients understand why they may experience stronger or milder appetite suppression, and whether tirzepatide, semaglutide, or a dual compound like GLP-Squared may deliver the best results
Quisque ante sem, faucibus id velit eget, bibendum sodales purus
2 Chronic kidney disease poses a significant risk of kidney failure, cardiovascular events and death, 3 highlighting the critical need for research into its prevention and treatment
One study of people with obesity (but not diabetes) found that those taking a GLP-1 were 36% more likely to develop acne within three months of starting the medication than were those not taking the drugs
Gomez QuinteroDFKokCRHutkinsR
Quanti farmaci per lobesit sono disponibili oggi in Italia